The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of N-Methyl-d-aspartate Receptor Subunit 1 in Brain Cancer Cells for Alzheimer’s Disease Application

Abstract

The aim of this study is to fabricate reactive oxygen species (ROS)-sensitive nanoparticles composed of succinyl β-cyclodextrin (bCDsu), memantine and thioketal linkages for application in Alzheimer’s disease, and to investigate the suppression of N-methyl-d-aspartate (NMDA) receptor 1 (NMDAR1) in cells. Thioketal diamine was attached to the carboxyl group of bCDsu to produce thioketal-decorated bCDsu conjugates (bCDsu-thioketal conjugates) and memantine was conjugated with thioketal dicarboxylic acid (memantine-thioketal carboxylic acid conjugates). Memantine-thioketal carboxylic acid conjugates were attached to bCDsu-thioketal conjugates to produce bCDsu-thioketal-memantine (bCDsuMema) conjugates. SH-SY5Y neuroblastoma cells and U87MG cells were used for NMDAR1 protein expression and cellular oxidative stress. Nanoparticles of bCDsuMema conjugates were prepared by means of a dialysis procedure. Nanoparticles of bCDsuMema conjugates had small particle sizes less than 100 nm and their morphology was found to be spherical in transmission electron microscopy observations (TEM). Nanoparticles of bCDsuMema conjugates responded to H2O2 and disintegrated or swelled in aqueous solution. Then, the nanoparticles rapidly released memantine according to the concentration of H2O2. In an in vivo animal imaging study, thioketal-decorated nanoparticles labelled with fluorescent dye such as chlorin e6 (Ce6) showed that the fluorescence intensity was stronger in the brain than in other organs, indicating that bCDsuMema nanoparticles can efficiently target the brain. When cells were exposed to H2O2, the viability of cells was time-dependently decreased. Memantine or bCDsuMema nanoparticles did not practically affect the viability of the cells. Furthermore, a western blot assay showed that the oxidative stress produced in cells using H2O2 increased the expression of NMDAR1 protein in both SH-SY5Y and U87MG cells. Memantine or bCDsuMema nanoparticles efficiently suppressed the NMDAR1 protein, which is deeply associated with Alzheimer’s disease. Fluorescence microscopy also showed that H2O2 treatment induced green fluorescence intensity, which represents intracellular ROS levels. Furthermore, H2O2 treatment increased the red fluorescence intensity, which represents the NMDAR1 protein, i.e., oxidative stress increases the expression of NMDAR1 protein level in both SH-SY5Y and U87MG cells. When memantine or bCDsuMema nanoparticles were treated in cells, the oxidative stress-mediated expression of NMDAR1 protein in cells was significantly decreased, indicating that bCDsuMema nanoparticles have the capacity to suppress NMDAR1 expression in brain cells, which has relevance in terms of applications in Alzheimer’s disease.

Antitumor Effect of Photodynamic Therapy/Sonodynamic Therapy/Sono-Photodynamic Therapy of Chlorin e6 and Other Applications

“…36 The killing effect of Ce6-PDT on cells became stronger as the photosensitizer concentration increased, and at 8.0 g/mL, the apoptosis rate of SW260 exceeded 60%. Other studies have shown that Ce6 photodynamic therapy can treat triple-negative breast cancer, 37 brain cancer, 38 ovarian cancer, 39 and colon cancer. 40 2.3.…”

Identification and validation of aging-related genes in atrial fibrillation

“…Inhibition of iGluRs has demonstrated the ability to reduce AF incidence and alleviate AF progression in AF models using isolated rat hearts [47]. Furthermore, numerous studies have provided evidence of memantine's capacity to ameliorate oxidative damage in various diseases [48][49][50]. In human umbilical vein endothelial cells, memantine mitigated inflammation, oxidative stress, and apoptosis induced by oxidized low-density lipoprotein through the activation of the BDNF/TrkB signaling pathway [50].…”

Imaging Technologies for Cerebral Pharmacokinetic Studies: Progress and Perspectives

“…Fluorescence imaging of isolated brain tissue can also measure the ability of different nano-agents to penetrate the blood–brain barrier by quantifying the fluorescence intensity of the brain [ 7 ]. The fluorescence intensity of the fluorescently Ce6-labeled bCDsu-thioketal-memantine (bCDsuMema) nanoparticles was strongest in the brain, suggesting that nanoparticles can effectively target the brain, providing a promising candidate for the inhibition of Alzheimer’s disease [ 8 ]. Alata et al [ 9 ] used in situ brain perfusion (ISPB) combined with optical brain imaging and distribution volume evaluation to determine brain accumulation of sdAbs fused to mouse Fc (sdAb-mFc) after penetration disruption of BBB.…”